Semin Respir Crit Care Med 2022; 43(01): 010-027
DOI: 10.1055/s-0041-1741053
Review Article

Intra-abdominal Infections

Lena M. Napolitano

Abstract

Intra-abdominal infections (IAIs) are a common cause of sepsis, and frequently occur in intensive care unit (ICU) patients. IAIs include many diagnoses, including peritonitis, cholangitis, diverticulitis, pancreatitis, abdominal abscess, intestinal perforation, abdominal trauma, and pelvic inflammatory disease. IAIs are the second most common cause of infectious morbidity and mortality in the ICU after pneumonia. IAIs are also the second most common cause of sepsis in critically ill patients, and affect approximately 5% of ICU patients. Mortality with IAI in ICU patients ranges from 5 to 50%, with the wide variability related to the specific IAI present, associated patient comorbidities, severity of illness, and organ dysfunction and failures. It is important to have a comprehensive understanding of IAIs as potential causes of life-threatening infections in ICU patients to provide the best diagnostic and therapeutic care for optimal patient outcomes in the ICU.



Publication History

Article published online:
16 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Napolitano LM. Perspectives in surgical infections: what does the future hold?. Surg Infect (Larchmt) 2010; 11 (02) 111-123
  • 2 Vincent JL, Rello J, Marshall J. et al; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302 (21) 2323-2329
  • 3 Friedrich AK, Cahan M. Intraabdominal infections in the intensive care unit. J Intensive Care Med 2014; 29 (05) 247-254
  • 4 Barie PS, Hydo LJ, Eachempati SR. Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surg Infect (Larchmt) 2004; 5 (04) 365-373
  • 5 De Waele J, Lipman J, Sakr Y. et al; EPIC II Investigators. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis 2014; 14: 420
  • 6 Volakli E, Spies C, Michalopoulos A, Groeneveld AB, Sakr Y, Vincent JL. Infections of respiratory or abdominal origin in ICU patients: what are the differences?. Crit Care 2010; 14 (02) R32
  • 7 Alberti C, Brun-Buisson C, Burchardi H. et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28 (02) 108-121
  • 8 Vincent JL, Sakr Y, Sprung CL. et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34 (02) 344-353
  • 9 Sakr Y, Jaschinski U, Wittebole X. et al; ICON Investigators. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis 2018; 5 (12) ofy313
  • 10 Vincent JL, Sakr Y, Singer M. et al; EPIC III Investigators. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 2020; 323 (15) 1478-1487
  • 11 Yin M, Tambyah PA, Perencevich EN. Infection, antibiotics, and patient outcomes in the intensive care unit. JAMA 2020; 323 (15) 1451-1452
  • 12 van de Groep K, Verhoeff TL, Verboom DM. et al; MARS Consortium. Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care 2019; 52: 258-264
  • 13 Bass GA, Dzierba AL, Taylor B, Lane-Fall M, Kaplan LJ. Tertiary peritonitis: considerations for complex team-based care. Eur J Trauma Emerg Surg 2021; (epub ahead of print) DOI: 10.1007/s00068-021-01750-9.
  • 14 Sartelli M, Catena F, Abu-Zidan FM. et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg 2017; 12: 22
  • 15 Sartelli M, Catena F, Di Saverio S. et al. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg 2014; 9 (01) 22
  • 16 Sartelli M, Catena F, Ansaloni L. et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg 2012; 7 (01) 36
  • 17 Sartelli M, Catena F, Ansaloni L. et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg 2014; 9: 37
  • 18 Solomkin JS, Mazuski JE, Bradley JS. et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50 (02) 133-164
  • 19 Sartelli M, Chichom-Mefire A, Labricciosa FM. et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2017; 12: 29
  • 20 Biggins SW, Angeli P, Garcia-Tsao G. et al. Diagnosis, evaluation and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 74 (02) 1014-1048
  • 21 Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rep 2010; 12 (05) 345-353
  • 22 Mazuski JE, Tessier JM, May AK. et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 2017; 18 (01) 1-76
  • 23 Wu XW, Zheng T, Hong ZW. et al. Current progress of source control in the management of intra-abdominal infections. Chin J Traumatol 2020; 23 (06) 311-313
  • 24 Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE. Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia. Surg Infect (Larchmt) 2015; 16 (06) 785-793
  • 25 van Ruler O, Mahler CW, Boer KR. et al; Dutch Peritonitis Study Group. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007; 298 (08) 865-872
  • 26 Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care 2015; 19: 63
  • 27 Kumar A, Roberts D, Wood KE. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34 (06) 1589-1596
  • 28 Sartelli M, Weber DG, Ruppé E. et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg 2016; 11: 33 [ Erratum in: World J Emerg Surg. 2017 Aug 2;12:35. PMID: 27429642; PMCID: PMC4946132]
  • 29 Timsit JF, Bassetti M, Cremer O. et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med 2019; 45 (02) 172-189
  • 30 Sartelli M, Catena F, Ansaloni L, Coccolini F, Di Saverio S, Griffiths EA. Duration of antimicrobial therapy in treating complicated intra-abdominal infections: a comprehensive review. Surg Infect (Larchmt) 2016; 17 (01) 9-12
  • 31 Sawyer RG, Claridge JA, Nathens AB. et al; STOP-IT Trial Investigators. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015; 372 (21) 1996-2005
  • 32 Hassinger TE, Guidry CA, Rotstein OD. et al. Longer-duration antimicrobial therapy does not prevent treatment failure in high-risk patients with complicated intra-abdominal infections. Surg Infect (Larchmt) 2017; 18 (06) 659-663
  • 33 Rattan R, Allen CJ, Sawyer RG. et al. Percutaneously drained intra-abdominal infections do not require longer duration of antimicrobial therapy. J Trauma Acute Care Surg 2016; 81 (01) 108-113
  • 34 Rattan R, Allen CJ, Sawyer RG. et al. Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg 2016; 222 (04) 440-446
  • 35 Smith SE, Rumbaugh KA, May AK. Evaluation of a short course of antimicrobial therapy for complicated intra-abdominal infections in critically ill surgical patients. Surg Infect (Larchmt) 2017; 18 (06) 742-750
  • 36 Montravers P, Tubach F, Lescot T. et al; DURAPOP Trial Group. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 2018; 44 (03) 300-310
  • 37 Abidi HH, Sawyer RG. More evidence for shortening antibiotic therapy in peritonitis: the DURAPOP trial. J Thorac Dis 2018; 10 (Suppl. 26) S3160-S3161
  • 38 Yokoe M, Hata J, Takada T. et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25 (01) 41-54
  • 39 Kiewiet JJ, Leeuwenburgh MM, Bipat S, Bossuyt PM, Stoker J, Boermeester MA. A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis. Radiology 2012; 264 (03) 708-720
  • 40 Okamoto K, Suzuki K, Takada T. et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25 (01) 55-72
  • 41 Buckman SA, Mazuski JE. JAMA Network Clinical Guideline Synopsis. Review of the Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. JAMA Surg 2019; 154 (09) 873-874
  • 42 Hall J, Hardiman K, Lee S. et al; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the treatment of left-sided colonic diverticulitis. Dis Colon Rectum 2020; 63 (06) 728-747
  • 43 Sartelli M, Weber DG, Kluger Y. et al. 2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting. World J Emerg Surg 2020; 15 (01) 32
  • 44 Peery AF, Shaukat A, Strate LL. AGA clinical practice update on medical management of colonic diverticulitis: expert review. Gastroenterology 2021; 160 (03) 906-911.e1
  • 45 Broderick-Villa G, Burchette RJ, Collins JC, Abbas MA, Haigh PI. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg 2005; 140 (06) 576-581 , discussion 581–583
  • 46 Francis NK, Sylla P, Abou-Khalil M. et al. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc 2019; 33 (09) 2726-2741
  • 47 Wexner SD, Talamini MA. EAES/SAGES consensus conference on acute diverticulitis: a paradigm shift in the management of acute diverticulitis. Surg Endosc 2019; 33 (09) 2724-2725
  • 48 Morris AM, Regenbogen SE, Hardiman KM, Hendren S. Sigmoid diverticulitis: a systematic review. JAMA 2014; 311 (03) 287-297
  • 49 Regenbogen SE, Hardiman KM, Hendren S, Morris AM. Surgery for diverticulitis in the 21st century: a systematic review. JAMA Surg 2014; 149 (03) 292-303
  • 50 Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg 1978; 12: 85-109
  • 51 Strate LL, Morris AM. Epidemiology, pathophysiology and treatment of diverticulitis. Gastroenterology 2019; 156 (05) 1282-1298.e1
  • 52 Lambrichts DP, Edomskis PP, van der Bogt RD, Kleinrensink GJ, Bemelman WA, Lange JF. Sigmoid resection with primary anastomosis versus the Hartmann's procedure for perforated diverticulitis with purulent or fecal peritonitis: a systematic review and meta-analysis. Int J Colorectal Dis 2020; 35 (08) 1371-1386
  • 53 Leppäniemi A, Tolonen M, Tarasconi A. et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 2019; 14: 27
  • 54 De Waele JJ, Rello J, Anzueto A. et al; EPIC II Investigators. Infections and use of antibiotics in patients admitted for severe acute pancreatitis: data from the EPIC II study. Surg Infect (Larchmt) 2014; 15 (04) 394-398
  • 55 Garret C, Canet E, Corvec S. et al. Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study. Ann Intensive Care 2020; 10 (01) 82
  • 56 van Santvoort HC, Besselink MG, Bakker OJ. et al; Dutch Pancreatitis Study Group. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 2010; 362 (16) 1491-1502
  • 57 Warshaw AL. Improving the treatment of necrotizing pancreatitis–a step up. N Engl J Med 2010; 362 (16) 1535-1537
  • 58 Hollemans RA, Bakker OJ, Boermeester MA. et al; Dutch Pancreatitis Study Group. Superiority of step-up approach vs open necrosectomy in long-term follow-up of patients with necrotizing pancreatitis. Gastroenterology 2019; 156 (04) 1016-1026
  • 59 Baron TH, DiMaio CJ, Wang AY, Morgan KA. American Gastroenterological Association Clinical Practice Update: management of pancreatic necrosis. Gastroenterology 2020; 158 (01) 67-75.e1